IPCALAB Stock View

IPCA Laboratories Ltd

IPCALAB Stock View

(NSE)

Trade

₹ 894.25

-3.50 | -0.39

Market Cap ₹( Cr.)
226,875.00

Proj. P/E (x)
30.29

Proj. P/BV (x)
3.54

Proj. ROE (%)
12.23

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)
69,869.47

HOLD

Last Updated On.
17-Sep-2023

 

Copy Link

Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data